Spero Therapeutics, Inc. (SPRO)
2.74
-0.06
(-2.14%)
USD |
NASDAQ |
Apr 24, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Spero Therapeutics Shareholders Equity (Quarterly) : 59.02M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 198.82M |
| SELLAS Life Sciences Group, Inc. | 70.87M |
| Nephros, Inc. | 10.20M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.92M |
| Total Liabilities (Quarterly) | 9.898M |
| Debt to Equity Ratio | 0.0491 |
| Current Ratio | 7.588 |
| Net Debt Paydown Yield | 0.26% |